Development of anti-VEGF prolonged release drug delivery system containing PLL dendrimer and hyaluronic acid

Basit Öğe Kaydı
dc.authorid0000-0003-4147-6729en_US
dc.authorid0000-0003-2108-2458en_US
dc.authorid0000-0003-1127-9273en_US
dc.authorid0000-0002-4910-9459en_US
dc.authorid0000-0003-2940-3172en_US
dc.contributor.authorGedik, Gülşah
dc.contributor.authorÖztabağ, Cansu Kara
dc.contributor.authorSarp, Önder
dc.contributor.authorNazlı, Hakan
dc.contributor.authorTıranbeşli, Görkem
dc.contributor.authorKurt, Akif Hakan
dc.date.accessioned2024-01-15T11:48:10Z
dc.date.available2024-01-15T11:48:10Z
dc.date.issued2022en_US
dc.departmentBAİBÜ, Lisansüstü Eğitim Enstitüsü, Sağlık Bilimleri, Sinir Bilimleri Ana Bilim Dalıen_US
dc.descriptionThis work was supported by Trakya University Scientific Research Projects Unit (Grant no. 2018/196).en_US
dc.description.abstractIn this study we aimed to develop anti-vascular endothelial growth factors (anti-VEGF) drug delivery systems that long-term sustained release using dendrimer technology and to evaluate its possible cytotoxic effects on the retina pigment epithelial cells (ARPE-19) and the irritation potential by Hen's Egg Test on a chorioallantoic membrane (HET-CAM) analysis. The drug carrier gel formulation was prepared by adding hyaluronic acid (HA) after bevacizumab (BEV) was complexed with poly-L-lysine (PLL) dendrimer. The formulations were determined by the particle size, polydispersity index (PDI) values, zeta potential, pH, optical clarity, and their content. The UV- spectrophotometric analytical methods were developed, validated and applied for the kinetic studies. Prolonged BEV release from formulations has been observed for up to 21 days. Cell viability was evaluated with the XTT assay. VEGF and BEV levels in the medium were measured using a human VEGF and BEV ELISA kit, respectively. HET-CAM assays were conducted to determine the irritation potential. The clarity of gel formulation was found to be clear and satisfactory (double +). The pH of gel formulation ranged between 6.39 and 6.95. The zeta potential of formulations ranged between +3.9 and -1.5 mV. The particle size of formulations ranged between 15 and 302 nm. The loading efficiency (LE) of the complex formulation was found 79.04%. The formulation's kinetic behavior was determined by the Higuchi and Korsmeyer-Peppas model. The formulations did not cause any irritation. According to the results obtained, gel formulation was innovative, effective and suitable for treatment. However, animal experiments and clinical studies should also be performed.en_US
dc.description.sponsorshipTrakya University Scientific Research Projects Unit [2018/196]en_US
dc.identifier.citationGedik, G., Oztabag, C. K., Sarp, O., Nazli, H., Tiranbesli, G., Kurt, A. H., ... & Ayaz, L. (2022). Development of Anti-VEGF Prolonged Release Drug Delivery System Containing PLL Dendrimer and Hyaluronic Acid. Russian Journal of Bioorganic Chemistry, 48(6), 1348-1361.en_US
dc.identifier.doi10.1134/S1068162022060115
dc.identifier.endpage1361en_US
dc.identifier.issn1068-1620
dc.identifier.issn1608-330X
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-85140250100en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage1348en_US
dc.identifier.urihttp://dx.doi.org/10.1134/S1068162022060115
dc.identifier.urihttps://hdl.handle.net/20.500.12491/11940
dc.identifier.volume48en_US
dc.identifier.wosWOS:000870655000013en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorÖztabağ, Cansu Kara
dc.language.isoenen_US
dc.publisherMaik Nauka/Interperiodica/Springeren_US
dc.relation.ispartofRussian Journal of Bioorganic Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - İdari Personel ve Öğrencien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-VEGFen_US
dc.subjectBevacizumaben_US
dc.subjectPoly-L-Iysine Dendrimeren_US
dc.subjectBevacizumab Avastinen_US
dc.subjectIntravitrealen_US
dc.subjectComplexesen_US
dc.titleDevelopment of anti-VEGF prolonged release drug delivery system containing PLL dendrimer and hyaluronic aciden_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
gulsah-gedik.pdf
Boyut:
1.75 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Lisansüstü Eğitim Enstitüsü Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu